![Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2022/03/Feature-Image-Gastroenterology-11-Supplement-1-ECCO-940x563.jpg)
Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal
![ECCO Branch In Almere, The Netherlands. ECCO Sko A/S Is A Danish Shoe Manufacturer And Retailer Founded In 1963 By Karl Toosbuy In Bredebro, Denmark. Stock Photo, Picture and Royalty Free Image. ECCO Branch In Almere, The Netherlands. ECCO Sko A/S Is A Danish Shoe Manufacturer And Retailer Founded In 1963 By Karl Toosbuy In Bredebro, Denmark. Stock Photo, Picture and Royalty Free Image.](https://previews.123rf.com/images/bwylezich/bwylezich2009/bwylezich200900070/155243126-ecco-branch-in-almere-the-netherlands-ecco-sko-a-s-is-a-danish-shoe-manufacturer-and-retailer.jpg)
ECCO Branch In Almere, The Netherlands. ECCO Sko A/S Is A Danish Shoe Manufacturer And Retailer Founded In 1963 By Karl Toosbuy In Bredebro, Denmark. Stock Photo, Picture and Royalty Free Image.
![Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter](https://pbs.twimg.com/media/DVn1ixWV4AAr0Yo.jpg)
Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter
Tauseef Ali MD, FACG AGAF FACP on Twitter: "Sunday Review #IBD101 Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial https://t.co/KPVL2TcKX9" / Twitter
![ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach](https://researchoutreach.org/wp-content/uploads/2018/06/158_20150925_new-1200x675.jpg)
ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach
![Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease](https://www.dldjournalonline.com/cms/asset/4203302f-15c1-4c6a-b6e3-b0dc2193e743/gr1.jpg)
Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
![Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter](https://pbs.twimg.com/media/DVn1I0CVwAAVbci.jpg)
Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter
![PDF) Young adults living with inflammatory bowel disease. A thematic synthesis of patient experience. PDF) Young adults living with inflammatory bowel disease. A thematic synthesis of patient experience.](https://i1.rgstatic.net/publication/325952662_Young_adults_living_with_inflammatory_bowel_disease_A_thematic_synthesis_of_patient_experience/links/5b2ea8854585150d23caa253/largepreview.png)
PDF) Young adults living with inflammatory bowel disease. A thematic synthesis of patient experience.
![PDF) Abstract: OP036 Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial PDF) Abstract: OP036 Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial](https://i1.rgstatic.net/publication/313467511_Abstract_OP036_Short_duration_low_intensity_pooled_faecal_microbiota_transplantation_induces_remission_in_patients_with_mild-moderately_active_ulcerative_colitis_a_randomised_controlled_trial/links/5a78e938aca2722e4df31b42/largepreview.png)